Pharmacokinetic issues for antibiotics in the critically ill patient
JA Roberts, J Lipman - Critical care medicine, 2009 - journals.lww.com
Objective: To discuss the altered pharmacokinetic properties of selected antibiotics in
critically ill patients and to develop basic dose adjustment principles for this patient …
critically ill patients and to develop basic dose adjustment principles for this patient …
Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials
SK Kasiakou, GJ Sermaides… - The Lancet Infectious …, 2005 - thelancet.com
Intermittent intravenous administration of antibiotics is the first-line approach in the
management of severe infections worldwide. However, the potential benefits of alternate …
management of severe infections worldwide. However, the potential benefits of alternate …
Breaking down the breakpoints: rationale for the 2022 Clinical and Laboratory Standards Institute revised piperacillin-tazobactam breakpoints against …
PD Tamma, PNA Harris, AJ Mathers… - Clinical Infectious …, 2023 - academic.oup.com
Piperacillin-tazobactam (PTZ) is one of the most common antibiotics administered to
hospitalized patients. Its broad activity against gram-negative, gram-positive, and anaerobic …
hospitalized patients. Its broad activity against gram-negative, gram-positive, and anaerobic …
Piperacillin penetration into tissue of critically ill patients with sepsis—bolus versus continuous administration?
JA Roberts, MS Roberts, TA Robertson… - Critical care …, 2009 - journals.lww.com
Objective: To describe a pharmacokinetic model of piperacillin concentrations in plasma and
subcutaneous tissue when administered by bolus dosing and continuous infusion in …
subcutaneous tissue when administered by bolus dosing and continuous infusion in …
Piperacillin–tazobactam: a β-lactam/β-lactamase inhibitor combination
A Gin, L Dilay, JA Karlowsky, A Walkty… - Expert review of anti …, 2007 - Taylor & Francis
Piperacillin–tazobactam is a β-lactam/β-lactamase inhibitor combination with a broad
spectrum of antibacterial activity that includes Gram-positive and-negative aerobic and …
spectrum of antibacterial activity that includes Gram-positive and-negative aerobic and …
Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized …
WK Lau, D Mercer, KM Itani, DP Nicolau… - Antimicrobial agents …, 2006 - Am Soc Microbiol
The purpose of this randomized, multicenter, open-label study was to compare the
continuous infusion of piperacillin-tazobactam with the standard intermittent infusion in 262 …
continuous infusion of piperacillin-tazobactam with the standard intermittent infusion in 262 …
Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion
L Lorente, A Jiménez, MM Martín, JL Iribarren… - International journal of …, 2009 - Elsevier
The standard mode of administration of piperacillin treatment is by intermittent infusion.
However, continuous infusion may be advantageous as β-lactam antibiotics exhibit time …
However, continuous infusion may be advantageous as β-lactam antibiotics exhibit time …
Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections
JR Shiu, E Wang, AM Tejani… - Cochrane Database of …, 2013 - cochranelibrary.com
Background Intravenous broad–spectrum antibiotics are indicated for the treatment of
severe infections. However, the emergence of infections caused by multiple‐drug resistant …
severe infections. However, the emergence of infections caused by multiple‐drug resistant …
Continuous infusion of beta-lactams
JW Mouton, AA Vinks - Current opinion in critical care, 2007 - journals.lww.com
Killing of bacteria by β-lactam antibiotics is maximal at around four times the minimum
inhibitory concentration in vitro. To ensure an optimal effect when treating severe infections …
inhibitory concentration in vitro. To ensure an optimal effect when treating severe infections …
Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection
C Li, JL Kuti, CH Nightingale… - Journal of …, 2005 - academic.oup.com
Objectives: We investigated the population pharmacokinetics and pharmacodynamics of
piperacillin and tazobactam in hospitalized patients. Patients and methods: A multicentre …
piperacillin and tazobactam in hospitalized patients. Patients and methods: A multicentre …